Hepatic steatosis in potential liver donor candidates has important implications towards outcomes of liver transplant recipients and donor safety. Hepatic steatosis in potential donors in excess of established but varying institutional thresholds are considered as grounds for donor ineligibility. However, negiblible/absent hepatic steatosis (<5%) is considered acceptable universally. Currently Liver biopsy is regarded as reference standard. We show in our study that MR-PDFF has very high NPV for excluding significant hepatic steatosis (>10%). Thus MRI-PDFF can be utilized for liver donor screening and obviates the need for liver biopsy when MRI-PDFF values are <5%
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords